Mengyue Lin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Aortic Dissection

Top Venues

Environmental science & technology

Risk management and healthcare policy

European journal of endocrinology

International journal of general medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mengyue Lin, Jingyi Yan, Junshuang Tang, Sirui Han, Pi Guo, Shiwan Wu, Liang Tao, Hongyan Xiao, Yequn Chen, Xuerui Tan
Air Pollutants and Mortality Risk in Patients with Aortic Dissection: Evidence from a Clinical Cohort, Single-Cell Sequencing, and Proteomics. Environmental science & technology 58 (15) (2024)
Mengyue Lin, Jingyi Yan, Junshuang Tang, Sirui Han, Pi Guo, Shiwan Wu, Liang Tao, Hongyan Xiao, Yequn Chen, Xuerui Tan
Air Pollutants and Mortality Risk in Patients with Aortic Dissection: Evidence from a Clinical Cohort, Single-Cell Sequencing, and Proteomics. Environmental science & technology 58 (15) (2024)
Mengyue Lin, Jingyi Yan, Junshuang Tang, Sirui Han, Pi Guo, Shiwan Wu, Liang Tao, Hongyan Xiao, Yequn Chen, Xuerui Tan
Air Pollutants and Mortality Risk in Patients with Aortic Dissection: Evidence from a Clinical Cohort, Single-Cell Sequencing, and Proteomics. Environmental science & technology (2024)
Mengyue Lin, Jingyi Yan, Junshuang Tang, Sirui Han, Pi Guo, Shiwan Wu, Liang Tao, Hongyan Xiao, Yequn Chen, Xuerui Tan
Air Pollutants and Mortality Risk in Patients with Aortic Dissection: Evidence from a Clinical Cohort, Single-Cell Sequencing, and Proteomics. Environmental science & technology 58 (15) (2024)
Mengyue Lin, Jingyi Yan, Junshuang Tang, Sirui Han, Pi Guo, Shiwan Wu, Liang Tao, Hongyan Xiao, Yequn Chen, Xuerui Tan
Air Pollutants and Mortality Risk in Patients with Aortic Dissection: Evidence from a Clinical Cohort, Single-Cell Sequencing, and Proteomics. Environmental science & technology 58 (15) (2024)
Lin Gan, Nan-Fang Li, Mulalibieke Heizati, Mengyue Lin, Qing Zhu, Jing Hong, Ting Wu, Ling Tong, Zuhere Xiamili, Yue Lin
Diurnal cortisol features with cardiovascular disease in hypertensive patients: a cohort study. European journal of endocrinology 187 (5) (2022)
Qing Zhu, Mulalibieke Heizhati, Mengyue Lin, Menghui Wang, Xiaoguang Yao, Lin Gan, Qin Luo, Weiwei Zhang, Jing Hong, Na Yue, Nan-Fang Li
Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study. Hypertension (Dallas, Tex. : 1979) 79 (4) (2022)
Mengyue Lin, Mulalibieke Heizhati, Lin Gan, Ling Yao, Wenbo Yang, Mei Li, Jing Hong, Zihao Wu, Hui Wang, Nan-Fang Li
Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder. Risk management and healthcare policy 15 (2022)
Mengyue Lin, Mulalibieke Heizhati, Lin Gan, Jing Hong, Ting Wu, Zuhere Xiamili, Ling Tong, Yue Lin, Nan-Fang Li
Higher plasma renin activity is associated with increased kidney damage risk in patients with hypertension and glucose metabolic disorders. Journal of clinical hypertension (Greenwich, Conn.) 24 (6) (2022)
Mengyue Lin, Mulalibieke Heizhati, Lin Wang, Lin Gan, Mei Li, Wenbo Yang, Ling Yao, Zhongrong Wang, Zhikang Yang, Reyila Abudoyreyimu, Zihao Wu, Nan-Fang Li
Prevalence and Associated Factors of Kidney Dysfunction in Patients with Hypertension and/or Diabetes Mellitus from a Primary Care Population in Northwest China. International journal of general medicine 14 (2021)
Mengyue Lin, Mulalibike Heizati, Lin Wang, Muyesaier Nurula, Zhikang Yang, Zhongrong Wang, Reyila Abudoyreyimu, Zihao Wu, Nanfang Li
A systematic review and meta-analysis of effects of spironolactone on blood pressure, glucose, lipids, renal function, fibrosis and inflammation in patients with hypertension and diabetes. Blood pressure 30 (3) (2021)
Nan-Fang Li, Mengyue Lin, Mulalibieke Heizhati, Lin Wang, Qin Luo, Yuanyuan Li, Jina Yili, Jing Hong, Xiaoguang Yao, Qing Zhu
Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial. BMJ open 10 (11) (2020)